Rk1 and Rg5 shared 44 putative targets associated with hepatocellular carcinoma, with enrichment analysis revealing that Rk1 may induce effects through inhibition of MAPK and NF-κB signal pathways [114]. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.